Clinical Trials in Solothurn, Switzerland
5 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation44 enrolled18 locationsNCT05718323
Recruiting
The Medacta International SMS Post-Marketing Surveillance Study
Traumatic ArthritisAvascular Necrosis of the Femoral HeadArthrosis+2 more
Medacta International SA550 enrolled4 locationsNCT02748408
Recruiting
Phase 3
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
European Organisation for Research and Treatment of Cancer - EORTC220 enrolled94 locationsNCT05512364
Recruiting
Phase 3
Colchicine After Electrocardioversion for Atrial Fibrillation
Atrial FibrillationCardiac Arrhythmia
University Hospital, Basel, Switzerland416 enrolled8 locationsNCT05890664
Recruiting
Not Applicable
Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy
Depression
PD Dr. med. Thorsten Mikoteit190 enrolled4 locationsNCT04507555
Recruiting
REDUCE LAP-HF III Corvia Protocol 1701
Heart Failure
Corvia Medical500 enrolled27 locationsNCT03191656